RTI Biologics, Inc. (RTI), the processor of orthopedic, dental, hernia and other biologic implants, has signed an agreement to provide spinal allograft implants to Aesculap Implant Systems, Inc. (Aesculap Implant Systems). Under the agreement, which is effective immediately, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems.
“We are pleased to work with Aesculap Implant Systems to deliver more sterilized spinal implants to surgeons,” said Brian K. Hutchison, RTI’s chairman and chief executive officer. “Through our agreement, we will be able to help even more patients with biologic solutions in spinal surgeries.”
“The needs of the spine surgeon are ever changing as they work to provide the best clinical outcomes possible for their patients. This supply agreement will allow Aesculap Implant Systems to provide new and different allograft product offerings to support surgeons in those efforts,” stated Ira Benson, vice president of marketing, Aesculap Implant Systems, Inc.